click below
click below
Normal Size Small Size show me how
m2018-drug-MOA
thru Neuro 2
drug | MOA |
---|---|
lithium carbonate Eskalith® | lithium alters sodium transport in nerve and muscle cells and effects a shift toward intraneuronal metabolism of catecholamines |
alprazolam Xanax® (Schedule IV) | mostly CNS by stimulating GABA receptor complex |
amitriptyline Elavil® | TCA (Tricyclic Antidepressant) prolong action of norepinephrine, dopamine, and seratonin by blocking reuptake |
amphetamine and dextroamphetamine sulfate Adderall® Schedule II | stimulates CNS activity; blocks reuptake and increases release of norepinephrine and dopamine in extraneuronal space (sympathomimetic) |
baclofen Lioresal® | centrally acting muscle relaxer |
betaxolol Betoptic | beta-blocker |
bupropion Wellbutrin®/Zyban® | Weak inhibitor of reuptake of norepinephrine and dopamine |
buspirone BuSpar® | partial dopamine and seratonin agonist |
carbamazepine Tegretol® | reduces post-tetanic potentiation, decreasing seizure spread; exact mechanism of action in trigeminal neuralgia or bipolar disorder unknown |
carbidopa/ levodopa Sinemet® | inhibits peripheral dopamine decarboxylation; crosses blood-brain barrier and serves as dopamine precursor |
chlorpromazine Thorazine® | principal pharmacological actions are psychotropic. It also exerts sedative and antiemetic activity |
diazepam Valium® (Schedule IV) | mostly CNS by stimulating GABA receptor complex |
donepezil Aricept ODT® | reversibly binds to and inactivates acetylcholinesterase (cholinesterase inhibitor) |
echothiophate Phospholine Iodide | cholinesterase inhibitor |
fentanyl Sublimaze® Schedule II | binds to various opioid receptors, producing analgesia and sedation (opioid agonist) |
fluoxetine Prozac® | SSRI (Selective Seratonin Reuptake Inhibitor) |
haloperidol Haldol® | Unknown |
Interferon beta 1b Betaseron® | binds to type 1 interferon receptors and activates tyrosine kinase, producing antiviral, antiproliferative, and immunomodulatory effects |
Interferon beta-1a Avonex® | binds to type 1 interferon receptors and activates tyrosine kinase, producing antiviral, antiproliferative, and immunomodulatory effects |
lidocaine Xylocaine® | inhibits Na ion channels, stabilizing neuronal cell membranes and inhibiting nerve impulse initiation and conduction (amide local anesthetic) |
memantine Namenda® | binds N-methyl-D-aspartate receptors, may slow Ca++ influx and nerve damage (NMDA receptor antagonist) |
methylphenidate Ritalin® Schedule II | stimulates CNS activity; blocks reuptake and increases release of norepinephrine and dopamine in extraneuronal space (sympathomimetic) |
midazolam Versed® Schedule IV | binds to benzodiazepine receptors; enhances GABA effects |
modafinil Provigil® Schedule II | binds to dopamine transporter, inhibiting dopamine reuptake |
phenelzine Nardil® | MAOi (MonoAmine Oxidase Inhibitor), monoamine oxidase enzyme widely distributed throughout body-lots of side effects, going from Nardil to Prozac wait 14 days, going from Prozac to Nardil, wait 5 weeks |
phenytoin Dilantin® | modulates neuronal voltage-dependent sodium and calcium channels |
pilocarpine Pilocar | cholinergic agonist |
pramipexole Mirapex® | stimulates dopamine receptors (dopamine agonist) |
risperidone Risperdal® | dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism |
selegiline Eldepryl® | selectively inhibits MAO type B, increasing extracellular dopamine in the striatum |
sodium thiopental Pentothal®Schedule II | alters sensory cortex, cerebellar, and motor activities; produces sedation, hypnosis, and anesthesia (barbiturate) |
sumatriptan Imitrex® | activates vascular serotonin 5-HT1 receptors, producing vasoconstriction (selective serotonin agonist) |
temazepam Restoril® Schedule IV | binds to benzodiazepine receptors; enhances GABA effects |
valproic acid Depakote® | increases GABA effects, may inhibit glutamate/NMDA receptor-mediated neuronal excitation |
venlafaxine Effexor® | SNRI (Seratonin Norepinephrine Reuptake Inhibitor) |
zolpidem Ambien® Schedule IV | interacts w/ GABA-benzodiazepine receptor complexes |